CLINICAL_TRIALS
trial_result
· 2013-12-18
Clinical Trial Update: Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder [Phase 3]
Summary
Phase 3 efficacy and safety study of vortioxetine in adults with major depressive disorder completed, with results posted in December 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED | Results posted: 2013-12-18